Literature DB >> 20036792

Clinical analysis of presbylarynx--vocal fold atrophy in elderly individuals.

Shingo Takano1, Miwako Kimura, Takaharu Nito, Hiroshi Imagawa, Ken-Ichi Sakakibara, Niro Tayama.   

Abstract

OBJECTIVE: The proportion of elderly Japanese is increasing significantly and aging society greatly influences the medical services. The number of elderly patients who visited out Voice Outpatient Clinic has been increasing in recent years. The aim of the present study was to analyze the trend in the number of patients with aging-related vocal fold atrophy, and to assess the characteristics of senile change of vocal function.
METHODS: A retrospective review of the 1999-2005 medical records of patients aged > or =65 years was conducted, and patients with presbylarynx were analyzed. We evaluated age, sex, occupation, maximal phonation time (MPT), and mean airflow rate (MFR) during comfortable phonation to assess the physiological characteristics of senile change of vocal function. We compared MFR of presbylarynx with those of normal elderly person.
RESULTS: The number of patients aged > or =65 who visited our clinic in the 7-year study period was 361, and 72 (20%) were diagnosed with vocal fold atrophy. They included 47 (65%) men and 25 (35%) women, with a mean age of 71 years (range, 65-89). Among these patients, 27 (38%) were still employed at the time of consultation, while 17 (24%) were retired, at least 26 jobs required voice skills; and 15 patients (21%) were involved in singing and recitation of poems. MPT correlated negatively with age, while MFR correlated positively with age.
CONCLUSION: The number of elderly patient with vocal fold atrophy increased gradually almost every year. The male patients account for 65%. Thirty-three percent of patient of the present study with presbylarynx were still in the workforce. MFR correlated positively and significantly with age. MFR was higher in presbylarynx than normal elderly person. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 20036792     DOI: 10.1016/j.anl.2009.11.013

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  7 in total

1.  Assessment of Clinical and Social Characteristics That Distinguish Presbylaryngis From Pathologic Presbyphonia in Elderly Individuals.

Authors:  Brianna K Crawley; Salem Dehom; Cedric Thiel; Jin Yang; Andrea Cragoe; Iman Mousselli; Priya Krishna; Thomas Murry
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-07-01       Impact factor: 6.223

2.  [Treatment of glottal gap].

Authors:  S Voigt-Zimmermann; C Arens
Journal:  HNO       Date:  2013-02       Impact factor: 1.284

3.  Effects of Age and Parkinson's Disease on the Relationship between Vocal Fold Abductory Kinematics and Relative Fundamental Frequency.

Authors:  Jennifer M Vojtech; Cara E Stepp
Journal:  J Voice       Date:  2022-04-05       Impact factor: 2.300

4.  The senile functional evolution of the larynx after supracricoid reconstructive surgery.

Authors:  Agostino Serra; Luigi Maiolino; Paola Di Mauro; Luisa Licciardello; Salvatore Cocuzza
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-30       Impact factor: 2.503

5.  Acoustic Measures of Voice and Physiologic Measures of Autonomic Arousal During Speech as a Function of Cognitive Load in Older Adults.

Authors:  Defne Abur; Megan K MacPherson; Adrianna C Shembel; Cara E Stepp
Journal:  J Voice       Date:  2021-01-25       Impact factor: 2.300

6.  Increased calcium channel in the lamina propria of aging rat.

Authors:  Ji Min Kim; Hyoung-Sam Heo; Sung-Chan Shin; Hyun-Keun Kwon; Jin-Choon Lee; Eui-Suk Sung; Hyung-Sik Kim; Gi Cheol Park; Byung-Joo Lee
Journal:  Aging (Albany NY)       Date:  2019-10-31       Impact factor: 5.682

7.  The Regenerative Effects of c-Met Agonistic Antibodies in Vocal Fold Atrophy.

Authors:  Hyunsu Choi; Seung-Shin Yu; Jiwon Choi; Choung-Soo Kim
Journal:  Int J Mol Sci       Date:  2022-07-15       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.